HCA Healthcare Inc to Post Q1 2018 Earnings of $2.07 Per Share, SunTrust Banks Forecasts (HCA)

HCA Healthcare Inc (NYSE:HCA) – Analysts at SunTrust Banks increased their Q1 2018 earnings per share (EPS) estimates for HCA Healthcare in a research note issued on Wednesday. SunTrust Banks analyst D. Macdonald now forecasts that the company will earn $2.07 per share for the quarter, up from their prior estimate of $1.79. SunTrust Banks currently has a “Positive” rating and a $120.00 target price on the stock. SunTrust Banks also issued estimates for HCA Healthcare’s Q2 2018 earnings at $2.17 EPS, Q4 2018 earnings at $2.55 EPS, FY2018 earnings at $8.62 EPS, Q4 2019 earnings at $2.75 EPS and FY2019 earnings at $9.52 EPS.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Tuesday, January 30th. The company reported $2.12 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.87 by $0.25. The business had revenue of $11.56 billion during the quarter, compared to analysts’ expectations of $11.19 billion. HCA Healthcare had a net margin of 4.89% and a negative return on equity of 49.49%. The company’s revenue for the quarter was up 8.7% on a year-over-year basis. During the same period in the previous year, the company earned $1.80 EPS.

Several other equities research analysts have also commented on the stock. Zacks Investment Research upgraded shares of HCA Healthcare from a “hold” rating to a “buy” rating and set a $113.00 price target on the stock in a research note on Friday, February 2nd. Sanford C. Bernstein reiterated a “market perform” rating and set a $116.00 price target (up from $105.00) on shares of HCA Healthcare in a research note on Thursday, February 1st. BMO Capital Markets lifted their price target on shares of HCA Healthcare from $96.00 to $115.00 and gave the stock an “outperform” rating in a research note on Thursday, February 1st. They noted that the move was a valuation call. Morgan Stanley lifted their price target on shares of HCA Healthcare from $84.00 to $91.00 and gave the stock an “underweight” rating in a research note on Thursday, February 1st. Finally, Royal Bank of Canada lifted their price target on shares of HCA Healthcare to $117.00 and gave the stock an “outperform” rating in a research note on Wednesday, January 31st. Three investment analysts have rated the stock with a sell rating, six have given a hold rating and eighteen have given a buy rating to the company. The stock has an average rating of “Buy” and a consensus price target of $103.65.

Shares of HCA Healthcare (HCA) opened at $97.84 on Monday. HCA Healthcare has a one year low of $71.18 and a one year high of $106.84. The company has a debt-to-equity ratio of -6.58, a quick ratio of 1.36 and a current ratio of 1.62. The company has a market cap of $35,340.00, a price-to-earnings ratio of 16.47, a P/E/G ratio of 0.98 and a beta of 0.48.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, March 30th. Shareholders of record on Thursday, March 1st will be paid a $0.35 dividend. The ex-dividend date of this dividend is Wednesday, February 28th. This represents a $1.40 dividend on an annualized basis and a yield of 1.43%.

In other HCA Healthcare news, SVP Victor L. Campbell sold 8,000 shares of HCA Healthcare stock in a transaction on Thursday, November 16th. The shares were sold at an average price of $75.82, for a total value of $606,560.00. Following the transaction, the senior vice president now directly owns 127,275 shares in the company, valued at $9,649,990.50. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider Charles J. Hall sold 35,949 shares of the business’s stock in a transaction dated Thursday, February 1st. The stock was sold at an average price of $103.09, for a total transaction of $3,705,982.41. Following the transaction, the insider now owns 111,237 shares in the company, valued at $11,467,422.33. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 284,469 shares of company stock worth $28,208,384. 2.90% of the stock is currently owned by company insiders.

Several institutional investors have recently modified their holdings of HCA. Longview Partners Guernsey LTD increased its stake in shares of HCA Healthcare by 22.6% during the third quarter. Longview Partners Guernsey LTD now owns 11,135,155 shares of the company’s stock worth $886,247,000 after acquiring an additional 2,053,701 shares during the period. APG Asset Management N.V. increased its stake in shares of HCA Healthcare by 141.4% during the third quarter. APG Asset Management N.V. now owns 3,423,381 shares of the company’s stock worth $272,467,000 after acquiring an additional 2,005,193 shares during the period. Assenagon Asset Management S.A. increased its stake in shares of HCA Healthcare by 1,500.3% during the third quarter. Assenagon Asset Management S.A. now owns 1,579,382 shares of the company’s stock worth $125,703,000 after acquiring an additional 1,480,690 shares during the period. American Century Companies Inc. increased its stake in shares of HCA Healthcare by 49.5% during the third quarter. American Century Companies Inc. now owns 2,558,216 shares of the company’s stock worth $203,608,000 after acquiring an additional 847,377 shares during the period. Finally, Schroder Investment Management Group increased its stake in shares of HCA Healthcare by 167.7% during the fourth quarter. Schroder Investment Management Group now owns 1,213,240 shares of the company’s stock worth $106,572,000 after acquiring an additional 760,099 shares during the period. Institutional investors and hedge funds own 74.89% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This news story was originally posted by American Banking News and is owned by of American Banking News. If you are accessing this news story on another website, it was stolen and republished in violation of US and international copyright and trademark legislation. The legal version of this news story can be accessed at https://www.americanbankingnews.com/2018/02/12/hca-healthcare-inc-to-post-q1-2018-earnings-of-2-07-per-share-suntrust-banks-forecasts-hca.html.

About HCA Healthcare

HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.

Earnings History and Estimates for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply